APO Research
Talk to an analyst

APO RESEARCH · REPORT

Follicle Stimulating Hormone

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Selected research

Market Structure

Global Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025184 pages

Choose your research edition.

Industry ResearchFollicle Stimulating Hormone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Follicle Stimulating Hormone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Follicle Stimulating Hormone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Follicle Stimulating Hormone Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.

There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.

Read the full market overview

This report provides an overview of the global Follicle Stimulating Hormone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Follicle Stimulating Hormone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Follicle Stimulating Hormone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Follicle Stimulating Hormone market size, projected growth trends, production technologies, key applications, and end-use industries.

Follicle Stimulating Hormone Segment by Company

Merck Serono

MSD

IBSA

Ferring

Livzon

Techwell

GenSci

Gedeon Richter

Teva

Follicle Stimulating Hormone Segment by Type

Recombinant FSH

Urinary FSH

Follicle Stimulating Hormone Segment by Application

Infertility Treatment

Assisted Reproductive Technology

Follicle Stimulating Hormone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Follicle Stimulating Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Follicle Stimulating Hormone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Follicle Stimulating Hormone Industry Trends Table 2. Follicle Stimulating Hormone Industry Drivers Table 3. Follicle Stimulating Hormone Industry Opportunities and Challenges Table 4. Follicle Stimulating Hormone Industry Restraints Table 5. Global Follicle Stimulating Hormone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Follicle Stimulating Hormone Sales by Manufacturers (k doses) & (2021-2026) Table 8. Global Follicle Stimulating Hormone Sales Market Share by Manufacturers Table 9. Global Follicle Stimulating Hormone Average Sales Price (USD/dose) of Manufacturers (2021-2026) Table 10. Global Follicle Stimulating Hormone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Follicle Stimulating Hormone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Follicle Stimulating Hormone Manufacturers, Product Type & Application Table 13. Global Follicle Stimulating Hormone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Follicle Stimulating Hormone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant FSH Table 17. Major Manufacturers of Urinary FSH Table 18. Global Follicle Stimulating Hormone Sales by Type 2021 VS 2025 VS 2032 (k doses) Table 19. Global Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 20. Global Follicle Stimulating Hormone Sales by Type (2027-2032) & (k doses) Table 21. Global Follicle Stimulating Hormone Sales Market Share by Type (2021-2026) Table 22. Global Follicle Stimulating Hormone Sales Market Share by Type (2027-2032) Table 23. Global Follicle Stimulating Hormone Revenue by Type 2021 VS 2025 VS 2032 (k doses) Table 24. Global Follicle Stimulating Hormone Revenue by Type (2021-2026) & (k doses) Table 25. Global Follicle Stimulating Hormone Revenue by Type (2027-2032) & (k doses) Table 26. Global Follicle Stimulating Hormone Revenue Market Share by Type (2021-2026) Table 27. Global Follicle Stimulating Hormone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Infertility Treatment Table 29. Major Manufacturers of Assisted Reproductive Technology Table 30. Global Follicle Stimulating Hormone Sales by Application 2021 VS 2025 VS 2032 (k doses) Table 31. Global Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 32. Global Follicle Stimulating Hormone Sales by Application (2027-2032) & (k doses) Table 33. Global Follicle Stimulating Hormone Sales Market Share by Application (2021-2026) Table 34. Global Follicle Stimulating Hormone Sales Market Share by Application (2027-2032) Table 35. Global Follicle Stimulating Hormone Revenue by Application 2021 VS 2025 VS 2032 (k doses) Table 36. Global Follicle Stimulating Hormone Revenue by Application (2021-2026) & (k doses) Table 37. Global Follicle Stimulating Hormone Revenue by Application (2027-2032) & (k doses) Table 38. Global Follicle Stimulating Hormone Revenue Market Share by Application (2021-2026) Table 39. Global Follicle Stimulating Hormone Revenue Market Share by Application (2027-2032) Table 40. Global Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 41. Global Follicle Stimulating Hormone Sales by Region (2021-2026) & (k doses) Table 42. Global Follicle Stimulating Hormone Sales Market Share by Region (2021-2026) Table 43. Global Follicle Stimulating Hormone Sales Forecasted by Region (2027-2032) & (k doses) Table 44. Global Follicle Stimulating Hormone Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 46. North America Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 47. North America Follicle Stimulating Hormone Sales by Country (2027-2032) & (k doses) Table 48. Europe Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 49. Europe Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 50. Europe Follicle Stimulating Hormone Sales by Country (2027-2032) & (k doses) Table 51. Asia Pacific Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 52. Asia Pacific Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 53. Asia Pacific Follicle Stimulating Hormone Sales by Country (2027-2032) & (k doses) Table 54. South America, Middle East and Africa Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 55. South America, Middle East and Africa Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 56. South America, Middle East and Africa Follicle Stimulating Hormone Sales by Country (2027-2032) & (k doses) Table 57. Global Follicle Stimulating Hormone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Follicle Stimulating Hormone Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Follicle Stimulating Hormone Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Follicle Stimulating Hormone Revenue Market Share by Region (2021-2026) Table 61. Global Follicle Stimulating Hormone Revenue Market Share by Region (2027-2032) Table 62. Merck Serono Company Information Table 63. Merck Serono Business Overview Table 64. Merck Serono Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck Serono Follicle Stimulating Hormone Product Portfolio Table 66. Merck Serono Recent Development Table 67. MSD Company Information Table 68. MSD Business Overview Table 69. MSD Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. MSD Follicle Stimulating Hormone Product Portfolio Table 71. MSD Recent Development Table 72. IBSA Company Information Table 73. IBSA Business Overview Table 74. IBSA Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. IBSA Follicle Stimulating Hormone Product Portfolio Table 76. IBSA Recent Development Table 77. Ferring Company Information Table 78. Ferring Business Overview Table 79. Ferring Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Ferring Follicle Stimulating Hormone Product Portfolio Table 81. Ferring Recent Development Table 82. Livzon Company Information Table 83. Livzon Business Overview Table 84. Livzon Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Livzon Follicle Stimulating Hormone Product Portfolio Table 86. Livzon Recent Development Table 87. Techwell Company Information Table 88. Techwell Business Overview Table 89. Techwell Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Techwell Follicle Stimulating Hormone Product Portfolio Table 91. Techwell Recent Development Table 92. GenSci Company Information Table 93. GenSci Business Overview Table 94. GenSci Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. GenSci Follicle Stimulating Hormone Product Portfolio Table 96. GenSci Recent Development Table 97. Gedeon Richter Company Information Table 98. Gedeon Richter Business Overview Table 99. Gedeon Richter Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Gedeon Richter Follicle Stimulating Hormone Product Portfolio Table 101. Gedeon Richter Recent Development Table 102. Teva Company Information Table 103. Teva Business Overview Table 104. Teva Follicle Stimulating Hormone Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Teva Follicle Stimulating Hormone Product Portfolio Table 106. Teva Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Follicle Stimulating Hormone Distributors List Table 110. Follicle Stimulating Hormone Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Follicle Stimulating Hormone Product Image Figure 2. Global Follicle Stimulating Hormone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Follicle Stimulating Hormone Market Size (2021-2032) & (US$ Million) Figure 4. Global Follicle Stimulating Hormone Sales (2021-2032) & (k doses) Figure 5. Global Follicle Stimulating Hormone Average Price (USD/dose) & (2021-2032) Figure 6. Global Top 5 and 10 Follicle Stimulating Hormone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant FSH Image Figure 9. Urinary FSH Image Figure 10. Global Follicle Stimulating Hormone Sales by Type (2021 VS 2025 VS 2032) & (k doses) Figure 11. Global Follicle Stimulating Hormone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Follicle Stimulating Hormone Sales Market Share by Type (2021-2032) Figure 13. Global Follicle Stimulating Hormone Revenue by Type (2021 VS 2025 VS 2032) & (k doses) Figure 14. Global Follicle Stimulating Hormone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Follicle Stimulating Hormone Revenue Market Share by Type (2021-2032) Figure 16. Infertility Treatment Image Figure 17. Assisted Reproductive Technology Image Figure 18. Global Follicle Stimulating Hormone Sales by Application (2021 VS 2025 VS 2032) & (k doses) Figure 19. Global Follicle Stimulating Hormone Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Follicle Stimulating Hormone Sales Market Share by Application (2021-2032) Figure 21. Global Follicle Stimulating Hormone Revenue by Application (2021 VS 2025 VS 2032) & (k doses) Figure 22. Global Follicle Stimulating Hormone Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Follicle Stimulating Hormone Revenue Market Share by Application (2021-2032) Figure 24. North America Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 25. North America Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 26. U.S. Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 27. Canada Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 28. Mexico Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 29. Europe Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 30. Europe Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 31. Germany Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 32. France Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 33. U.K. Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 34. Italy Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 35. Netherlands Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 36. Asia Pacific Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 37. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 38. China Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 39. Japan Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 40. South Korea Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 41. Southeast Asia Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 42. India Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 43. Australia Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 44. South America, Middle East and Africa Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 45. South America, Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 46. Brazil Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 47. South Africa Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 48. Saudi Arabia Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 49. Turkey Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 50. Argentina Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 51. UAE Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 52. Egypt Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 53. Chile Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (k doses) Figure 54. Global Follicle Stimulating Hormone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Follicle Stimulating Hormone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 57. North America Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 59. Europe Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Follicle Stimulating Hormone Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Follicle Stimulating Hormone Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant FSH
  • Urinary FSH
Applications
  • Infertility Treatment
  • Assisted Reproductive Technology
Companies covered
  • Merck Serono
  • MSD
  • IBSA
  • Ferring
  • Livzon
  • Techwell
  • GenSci
  • Gedeon Richter
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Follicle Stimulating Hormone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Follicle Stimulating Hormone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Follicle Stimulating Hormone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Follicle Stimulating Hormone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Follicle Stimulating Hormone Market Dynamics
  1. 2.1 Follicle Stimulating Hormone Industry Trends
  2. 2.2 Follicle Stimulating Hormone Industry Drivers
  3. 2.3 Follicle Stimulating Hormone Industry Opportunities and Challenges
  4. 2.4 Follicle Stimulating Hormone Industry Restraints
3 Follicle Stimulating Hormone Market by Manufacturers
  1. 3.1 Global Follicle Stimulating Hormone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Follicle Stimulating Hormone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Follicle Stimulating Hormone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Follicle Stimulating Hormone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Follicle Stimulating Hormone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Follicle Stimulating Hormone Manufacturers, Product Type & Application
  7. 3.7 Global Follicle Stimulating Hormone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Follicle Stimulating Hormone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Follicle Stimulating Hormone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Follicle Stimulating Hormone Tier 1, Tier 2, and Tier 3
4 Follicle Stimulating Hormone Market by Type
  1. 4.1 Follicle Stimulating Hormone Type Introduction
  2. 4.1.1 Recombinant FSH
  3. 4.1.2 Urinary FSH
  4. 4.2 Global Follicle Stimulating Hormone Sales by Type
  5. 4.2.1 Global Follicle Stimulating Hormone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Follicle Stimulating Hormone Sales by Type (2021-2032)
  7. 4.2.3 Global Follicle Stimulating Hormone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Follicle Stimulating Hormone Revenue by Type
  9. 4.3.1 Global Follicle Stimulating Hormone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Follicle Stimulating Hormone Revenue by Type (2021-2032)
  11. 4.3.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2021-2032)
5 Follicle Stimulating Hormone Market by Application
  1. 5.1 Follicle Stimulating Hormone Application Introduction
  2. 5.1.1 Infertility Treatment
  3. 5.1.2 Assisted Reproductive Technology
  4. 5.2 Global Follicle Stimulating Hormone Sales by Application
  5. 5.2.1 Global Follicle Stimulating Hormone Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Follicle Stimulating Hormone Sales by Application (2021-2032)
  7. 5.2.3 Global Follicle Stimulating Hormone Sales Market Share by Application (2021-2032)
  8. 5.3 Global Follicle Stimulating Hormone Revenue by Application
  9. 5.3.1 Global Follicle Stimulating Hormone Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Follicle Stimulating Hormone Revenue by Application (2021-2032)
  11. 5.3.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2021-2032)
6 Global Follicle Stimulating Hormone Sales by Region
  1. 6.1 Global Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Follicle Stimulating Hormone Sales by Region (2021-2032)
  3. 6.2.1 Global Follicle Stimulating Hormone Sales by Region (2021-2026)
  4. 6.2.2 Global Follicle Stimulating Hormone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Follicle Stimulating Hormone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Follicle Stimulating Hormone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Follicle Stimulating Hormone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Follicle Stimulating Hormone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Follicle Stimulating Hormone Revenue by Region
  1. 7.1 Global Follicle Stimulating Hormone Revenue by Region
  2. 7.1.1 Global Follicle Stimulating Hormone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Follicle Stimulating Hormone Revenue by Region (2021-2026)
  4. 7.1.3 Global Follicle Stimulating Hormone Revenue by Region (2027-2032)
  5. 7.1.4 Global Follicle Stimulating Hormone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Follicle Stimulating Hormone Revenue (2021-2032)
  8. 7.2.2 North America Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Follicle Stimulating Hormone Revenue (2021-2032)
  11. 7.3.2 Europe Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Follicle Stimulating Hormone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Follicle Stimulating Hormone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Serono
  2. 8.1.1 Merck Serono Company Information
  3. 8.1.2 Merck Serono Business Overview
  4. 8.1.3 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
  6. 8.1.5 Merck Serono Recent Developments
  7. 8.2 MSD
  8. 8.2.1 MSD Company Information
  9. 8.2.2 MSD Business Overview
  10. 8.2.3 MSD Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MSD Follicle Stimulating Hormone Product Portfolio
  12. 8.2.5 MSD Recent Developments
  13. 8.3 IBSA
  14. 8.3.1 IBSA Company Information
  15. 8.3.2 IBSA Business Overview
  16. 8.3.3 IBSA Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
  18. 8.3.5 IBSA Recent Developments
  19. 8.4 Ferring
  20. 8.4.1 Ferring Company Information
  21. 8.4.2 Ferring Business Overview
  22. 8.4.3 Ferring Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
  24. 8.4.5 Ferring Recent Developments
  25. 8.5 Livzon
  26. 8.5.1 Livzon Company Information
  27. 8.5.2 Livzon Business Overview
  28. 8.5.3 Livzon Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
  30. 8.5.5 Livzon Recent Developments
  31. 8.6 Techwell
  32. 8.6.1 Techwell Company Information
  33. 8.6.2 Techwell Business Overview
  34. 8.6.3 Techwell Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
  36. 8.6.5 Techwell Recent Developments
  37. 8.7 GenSci
  38. 8.7.1 GenSci Company Information
  39. 8.7.2 GenSci Business Overview
  40. 8.7.3 GenSci Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GenSci Follicle Stimulating Hormone Product Portfolio
  42. 8.7.5 GenSci Recent Developments
  43. 8.8 Gedeon Richter
  44. 8.8.1 Gedeon Richter Company Information
  45. 8.8.2 Gedeon Richter Business Overview
  46. 8.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
  48. 8.8.5 Gedeon Richter Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Follicle Stimulating Hormone Product Portfolio
  54. 8.9.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Follicle Stimulating Hormone Value Chain Analysis
  2. 9.1.1 Follicle Stimulating Hormone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Follicle Stimulating Hormone Production Mode & Process
  6. 9.2 Follicle Stimulating Hormone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Follicle Stimulating Hormone Distributors
  9. 9.2.3 Follicle Stimulating Hormone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst